Media coverage about Core Laboratories (NYSE:CLB) has trended somewhat positive recently, according to Accern. The research group scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Core Laboratories earned a coverage optimism score of 0.14 on Accern’s scale. Accern also assigned press coverage about the oil and gas company an impact score of 46.0837816461495 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Several equities research analysts recently commented on the stock. Loop Capital set a $115.00 price target on shares of Core Laboratories and gave the stock a “buy” rating in a report on Thursday. Zacks Investment Research lowered shares of Core Laboratories from a “hold” rating to a “sell” rating in a report on Tuesday, November 7th. UBS cut their price target on shares of Core Laboratories from $110.00 to $100.00 and set a “neutral” rating for the company in a report on Wednesday, October 25th. ABN Amro raised shares of Core Laboratories from a “hold” rating to a “buy” rating in a report on Wednesday, October 25th. Finally, Scotiabank set a $136.00 price target on shares of Core Laboratories and gave the stock a “hold” rating in a report on Wednesday, October 25th. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company’s stock. Core Laboratories presently has an average rating of “Hold” and a consensus target price of $110.40.

Core Laboratories (NYSE:CLB) traded up $0.74 during trading on Monday, hitting $101.74. 314,090 shares of the stock were exchanged, compared to its average volume of 574,397. Core Laboratories has a fifty-two week low of $86.55 and a fifty-two week high of $125.83. The stock has a market capitalization of $4,470.00, a price-to-earnings ratio of 55.19 and a beta of 1.55. The company has a debt-to-equity ratio of 1.53, a current ratio of 2.18 and a quick ratio of 1.81.

Core Laboratories (NYSE:CLB) last released its earnings results on Monday, October 23rd. The oil and gas company reported $0.48 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.44 by $0.04. Core Laboratories had a net margin of 12.06% and a return on equity of 52.89%. The business had revenue of $166.20 million during the quarter, compared to analyst estimates of $160.94 million. During the same quarter in the prior year, the firm earned $0.38 earnings per share. The company’s revenue for the quarter was up 1.4% compared to the same quarter last year. equities analysts expect that Core Laboratories will post 1.99 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 21st. Stockholders of record on Friday, October 20th were issued a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.16%. The ex-dividend date of this dividend was Thursday, October 19th. Core Laboratories’s payout ratio is 127.17%.

COPYRIGHT VIOLATION NOTICE: “Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Core Laboratories (CLB) Share Price” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Insider Buying and Selling by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with's FREE daily email newsletter.